Justin Bingham

Justin Bingham has a long and varied work experience. Justin began their career in 1997 as a Research Associate at BD. In 2000, they moved to GNF as a Research Scientist/Laboratory Manager. Justin then joined Pfizer in 2003 as a Scientist, Exploratory Technologies. In 2010, they became a Business Development Manager at MIcroStem, Inc. In 2012, they moved to Synthetic Genomics as the Director of Global Business Development. In 2014, they became the Head of Sales and Business Development at Codex DNA, a wholly owned subsidiary of Synthetic Genomics, Inc. In 2016, they took on the role of Strategic Advisor at CLEARiTIE. In 2017, they became the Global Senior Vice President, Head of Business Development at CENTOGENE. In 2019, they joined SOTERIA Precision Medicine Foundation, Inc. as a Board Member. Most recently, in 2022, they were appointed Chief Commercial Officer (CCO) at Nabsys.

Justin Bingham received their MBA from the University of California, San Diego - Rady School of Management in 2009, with a focus on Marketing & Business Development. Justin had previously earned their BA from the University of California, Santa Cruz in 1996, with a focus on Molecular, Cellular, Developmental Biology.